Key Points
Deutsche Bank raises UBS price target to CHF 40 with Buy rating.
UBS plans CHF 7B annual capital returns via buybacks and dividend hikes.
Strong Q1 results demonstrate successful Credit Suisse integration.
Stock trades at CHF 35.63 despite analyst upgrade, offering potential upside.
UBS stock is drawing investor attention on May 15 as Deutsche Bank Research upgraded its price target to CHF 40 with a Buy rating. The upgrade follows strong first-quarter results that have prompted analysts to raise expectations for capital returns to shareholders. Deutsche Bank’s team, led by expert Benjamin Goy, expects UBS to expand share buybacks to approximately USD 5 billion and increase its dividend by roughly 18 percent year-over-year. These moves would bring total capital returns to around CHF 7 billion, matching levels last seen before the Credit Suisse acquisition. The analyst upgrade reflects confidence in UBS’s financial recovery and shareholder-friendly strategy.
Analyst Upgrade Signals Confidence
Deutsche Bank Research’s decision to raise its UBS price target to CHF 40 represents a significant vote of confidence in the bank’s recovery trajectory. The upgrade comes after strong Q1 earnings that exceeded expectations, demonstrating UBS’s operational strength post-Credit Suisse integration. Analysts believe the bank has successfully stabilized its business and is now positioned to return capital to shareholders at pre-acquisition levels.
Capital Return Plans Boost Shareholder Appeal
UBS plans to significantly increase shareholder returns through multiple channels. The bank is expected to expand share buybacks to USD 5 billion while raising its dividend by approximately 18 percent compared to the prior year. Combined, these capital returns would total around CHF 7 billion annually, matching the levels UBS achieved before acquiring Credit Suisse. This dual approach—combining buybacks with dividend growth—appeals to both income-focused and total-return investors seeking exposure to Swiss banking strength.
Market Performance and Trading Activity
Despite the positive analyst upgrade, UBS shares traded lower on May 15, declining 1.6 percent to CHF 35.63 during midday trading on the SIX exchange. The stock opened at CHF 36.41 and hit an intraday low of CHF 35.58, with approximately 2 million shares changing hands. While the near-term price action appears soft, the CHF 40 price target represents meaningful upside potential from current levels, suggesting the market may be undervaluing the bank’s recovery narrative.
Recovery Momentum Continues
UBS’s ability to commit to substantial capital returns demonstrates the bank’s confidence in its earnings power and capital adequacy. The integration of Credit Suisse operations has progressed smoothly, allowing management to focus on profitability and shareholder returns. With strong Q1 results and analyst support, UBS appears well-positioned to execute its capital return strategy while maintaining the financial strength required by regulators.
Final Thoughts
UBS stock is gaining analyst support as Deutsche Bank raises its price target to CHF 40, reflecting confidence in the bank’s recovery and capital return plans. The expected CHF 7 billion in annual shareholder returns—combining USD 5 billion in buybacks with an 18 percent dividend increase—signals management’s confidence in earnings sustainability. While shares traded lower on May 15, the analyst upgrade and strong Q1 results suggest the market may be overlooking UBS’s improved financial position and shareholder-friendly strategy.
FAQs
Deutsche Bank Research raised its UBS price target to CHF 40 with a Buy rating, representing significant upside from May 15 trading levels.
UBS plans approximately CHF 7 billion in annual capital returns, including USD 5 billion in share buybacks and an 18 percent dividend increase.
UBS shares fell 1.6 percent on May 15, likely reflecting broader market conditions or profit-taking despite positive analyst sentiment and strong Q1 results.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)